Does Dr. CESAR ALFARO CRUZ have financial conflicts of interest?

Dr. CESAR ALFARO CRUZ (MD) has received a total of $1,375 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,375 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CESAR ALFARO CRUZ?

According to CMS Open Payments data, Dr. CESAR ALFARO CRUZ received funding from REGENERON HEALTHCARE SOLUTIONS ($474), ASTELLAS PHARMA US ($170), and ABBVIE ($117).

Does Dr. CESAR ALFARO CRUZ receive research grants or speaking fees?

Dr. CESAR ALFARO CRUZ has received $1,375 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CESAR ALFARO CRUZ

MDReal-Time Hydrated

Specialty: Ophthalmology

Practice Location: BRIDGEWATER, NJ 08807

NPI Number: 1740712637

LIFETIME INDUSTRY VALUE

$1,375

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALFARO CRUZ is a verified Ophthalmology practitioner based in BRIDGEWATER, NJ.

Between 2021 and 2025, Dr. ALFARO CRUZ had an overall industry promotional and research financial footprint of $1,375 as recorded in the federal CMS Open Payments database.

$1,375 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALFARO CRUZ's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $474 (representing 34.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$474

34.5%

ASTELLAS PHARMA US

Rank 2

$170

12.4%

ABBVIE

Rank 3

$117

8.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.